Buy BioAbsorb
BioAbsorb
Together they are designed to:
- Amplify glucose disposal and insulin sensitivity through dual AMPK activation and GLUT-4 translocation.
- Improve lipid and endothelial health by supporting healthy LDL-C, blood pressure and vascular function.
- Enhance mitochondrial energy production via coenzyme forms of vitamins B₁, B₂, B₅ and B₆.
- Maintain optimal one-carbon methylation and homocysteine balance with methyl-folate and methyl-cobalamin.
These complementary mechanisms make BioAbsorb a promising research candidate for studies of metabolic syndrome, cardiometabolic wellness and healthy aging.
BioAbsorb Ingredients (per capsule)
| Ingredient | Dose | Key Actions |
| Metformin | 125 mg | AMPK activation; insulin‐sensitizing & glucose-lowering [1] |
| DihydroBerberine | 125 mg | Highly absorbable berberine metabolite; improves glycemia & lipids [2] |
| Vitamin B₁ (Thiamin) | 12.5 mg | Pyruvate‐dehydrogenase cofactor; rescues endothelial dysfunction [3] |
| Vitamin B₂ (Riboflavin) | 12.5 mg | FAD precursor; lowers blood pressure in MTHFR-677TT carriers [4] |
| Vitamin B₅ (Pantethine) | 12.5 mg | CoA precursor; reduces LDL-C & non-HDL-C [5] |
| Vitamin B₆ (Pyridoxal-5-Phosphate) | 17.5 mg | PLP coenzyme; decreases plasma homocysteine [6] |
| Vitamin B₉ (Methyl-folate) | 200 mcg | Active folate; supports methylation & homocysteine control [7] |
| Vitamin B₁₂ (Methyl-cobalamin) | 50 mcg | Active B₁₂; neuroprotective, improves nerve conduction [8] |
Research Areas
- Glucose Disposal & Insulin Sensitivity
- Lipid & Cardiovascular Support
- Mitochondrial Energy Metabolism
- Methylation & Homocysteine Management
- Neuroprotection & Peripheral Nerve Health
Glucose Disposal & Insulin Sensitivity
Metformin activates hepatic and skeletal-muscle AMPK, suppressing gluconeogenesis and potentiating insulin-stimulated glucose uptake [1] . Dihydroberberine, a reduced berberine metabolite with far superior intestinal absorption, demonstrated greater area-under-the-curve exposure and produced acute reductions in post-prandial glucose in a randomized crossover pilot trial [2] .
Lipid & Endothelial Support
Pantethine (vitamin B₅ derivative) lowered total and LDL cholesterol by 11 % over 16 weeks in a triple-blinded, diet-controlled trial [5] . Low-dose thiamine reversed hyperglycemia-induced endothelial cell dysfunction in vitro, restoring migration capacity and reducing von Willebrand factor secretion [3] . Riboflavin supplementation (1.6 mg day⁻¹) produced clinically meaningful blood-pressure reductions in treated hypertensives carrying the MTHFR 677TT polymorphism [4] .
Methylation & Homocysteine Management
In a randomized controlled trial, combined methyl-folate (5-MTHF), PLP and methyl-cobalamin lowered plasma homocysteine by 30 % and LDL-C by 7.5 % after six months in adults with MTHFR/MTR/MTRR polymorphisms [7] . Independent PLP supplementation has likewise been shown to cut homocysteine while enhancing antioxidant capacity in postsurgical patients [6] .
Neuroprotection & Nerve Health
A 2020 systematic review and meta-analysis of randomized trials found that mecobalamin (methyl-B₁₂) significantly improved nerve-conduction velocity and overall clinical response in peripheral neuropathy, with a favorable safety profile [8] .
References
- Zhou G et al. Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest. 2001;108:1167-1174. https://pubmed.ncbi.nlm.nih.gov/11602624/
- Moon JM et al. Absorption kinetics of berberine and dihydroberberine and their impact on glycemia. Nutrients. 2022;14(1):124. https://pubmed.ncbi.nlm.nih.gov/35010998/
- Ascher E et al. Thiamine reverses hyperglycemia-induced dysfunction in cultured endothelial cells. Surgery. 2001;130:851-858. https://pubmed.ncbi.nlm.nih.gov/11685195/
- Wilson CP et al. Blood pressure in hypertensive individuals with the MTHFR 677TT genotype is responsive to riboflavin: targeted randomized trial. Hypertension. 2013;61:1302-1308. https://pubmed.ncbi.nlm.nih.gov/23608654/
- Evans M et al. Pantethine favorably alters LDL and non-HDL cholesterol in low-to-moderate risk subjects. Vasc Health Risk Manag. 2014;10:89-100. https://pubmed.ncbi.nlm.nih.gov/24600231/
- Cheng SB et al. Vitamin B-6 supplementation reduces plasma homocysteine in hepatocellular-carcinoma patients after resection. Biomed Res Int. 2016;2016:7658981. https://pubmed.ncbi.nlm.nih.gov/27051670/
- Pokushalov E et al. Methylfolate, PLP and methylcobalamin supplementation lowers homocysteine and LDL-C: randomized controlled trial. Nutrients. 2024;16:1550. https://pubmed.ncbi.nlm.nih.gov/38892484/
- Sawangjit R et al. Efficacy and safety of mecobalamin on peripheral neuropathy: systematic review and meta-analysis. J Altern Complement Med. 2020;26:1117-1129. https://pubmed.ncbi.nlm.nih.gov/32716261/
Note: BioAbsorb is supplied strictly for investigational research use only. It is not approved or intended for diagnostic or therapeutic applications in humans or animals.
Endotoxin BioAbsorb
×
Disclaimer: For Research Purposes Only
This content is provided strictly for research purposes and does not constitute an endorsement or recommendation for the non-laboratory application or improper handling of peptides designed for research. The information, including discussions about specific peptides and their researched benefits, is presented for informational purposes only and must not be construed as health, clinical, or legal guidance, nor an encouragement for non-research use in humans. Peptides described here are solely for use in structured scientific study by authorized individuals. We advise consulting with research experts, medical practitioners, or legal counsel prior to any decisions about obtaining or utilizing these peptides. The expectation of responsible, ethical utilization of this information for legitimate investigative and scholarly objectives is paramount. This notice is dynamic and governs all provided content on research peptides. . .

















